2016-07-27T10:17:52-05:00 2015-09-30 ERNST & YOUNG US LLP 111 MONUMENT CIRCLE SUITE 4000 INDIANAPOLIS IN 46207 990 2014-10-01 042263040 Dana-Farber Cancer Institute Inc % STEVEN CONNOLLY DANA 6176323000 450 Brookline Avenue BP418 Boston MA 02215 MICHAEL RENEY CFO 2016-07-20 CHRISTOPHER B BOGGS P00032493 3176817000 2014 2016-12-15 16:53:06Z Edward J Benz Jr MD 450 BROOKLINE AVE Boston MA 02215 1206044053 false X www.dana-farber.org X 1951 MA The mission of DFCI is to provide expert, compassionate care to COMPASSIONATE CARE TO CHILDREN AND ADULTS WITH CANCER & ADVANCE THE TREATMENT, CURE, AND PREVENTION OF CANCER & RELATED DISEASES. 66 58 5110 5000 0 0 403408212 427883303 672381913 746516458 206121 261256 43146433 28629127 1119142679 1203290144 501770 2320679 0 0 383724145 408356602 3291750 4081039 26147937 675695790 754092717 1063213455 1168851037 55929224 34439107 1950186370 2014332365 637235449 701988716 1312950921 1312343649 THE MISSION OF DANA-FARBER CANCER INSTITUTE IS TO PROVIDE EXPERT, COMPASSIONATE CARE TO CHILDREN AND ADULTS WITH CANCER WHILE ADVANCING THE UNDERSTANDING, DIAGNOSIS, TREATMENT, CURE, AND PREVENTION OF CANCER AND RELATED DISEASES. AS AN AFFILIATE OF HARVARD MEDICAL SCHOOL AND A COMPREHENSIVE CANCER CENTER DESIGNATED BY THE NATIONAL CANCER INSTITUTE, THE INSTITUTE ALSO PROVIDES TRAINING FOR NEW GENERATIONS OF PHYSICIANS AND SCIENTISTS, DESIGNS PROGRAMS THAT PROMOTE PUBLIC HEALTH PARTICULARLY AMONG HIGH-RISK AND UNDERSERVED POPULATIONS, AND DISSEMINATES INNOVATIVE PATIENT THERAPIES AND SCIENTIFIC DISCOVERIES TO OUR TARGET COMMUNITY ACROSS THE UNITED STATES AND THROUGHOUT THE WORLD. false false 632955508 746516458 Provided specialized, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. 286807964 Research at DFCI is staking out new territory in the fight against cancer, from advancing the understanding of the genetic makeup of cancer cells to developing novel therapies to diagnose, treat, and prevent the disease. 19230816 2320679 Through DFCI's community benefits programs, DFCI works in collaboration with community organizations to promote greater public health. See the community benefits report general explanation included in Schedule H. 938994288 true true false true false false false true false true true false false true true false false true false false true true false true true false true true true true true true false false false false false true false true false true true true false false false true true true true false true 530 0 true 5110 true false true CJ false false false true true false false false false X 66 58 true false false false false false false true true false false true true true true true true true true false AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X STEVEN CONNOLLY 6176323000 C/O DFCI 450 BROOKLINE AVE BP418 Boston MA 02215 X Alexander Susan Trustee 1.0 0.0 X 0 0 0 Bekenstein Joshua Trustee & Chairman 2.0 0.0 X X 0 0 0 Benz Edward J Jr MD Trustee, President and CEO 42.0 8.0 X X 1161596 136551 241642 Berkowitz Roger Trustee 1.0 0.0 X 0 0 0 Berylson Amy Trustee 1.0 0.0 X 0 0 0 Blum Betty Ann Trustee 1.0 0.0 X 0 0 0 Champa Michael Trustee 1.0 0.0 X 0 0 0 Chandra Monica Trustee 1.0 0.0 X 0 0 0 Cohen Marc Trustee 1.0 0.0 X 0 0 0 Countryman Gary L Trustee & Vice-Chairman 2.0 0.0 X X 0 0 0 Cox Howard Trustee 1.0 0.0 X 0 0 0 Curtin Neal J Esq Trustee & Secretary 2.0 0.0 X X 0 0 0 Daley Karen Trustee 1.0 0.0 X 0 0 0 DaSilva Kevin Trustee 1.0 0.0 X 0 0 0 Dobson Sean Trustee 1.0 0.0 X 0 0 0 Farrington Thomas Trustee 1.0 0.0 X 0 0 0 Fine James Trustee 1.0 0.0 X 0 0 0 Fine Stephen Trustee 1.0 0.0 X 0 0 0 First Deborah Trustee 1.0 0.0 X 0 0 0 Foulkes Helena Trustee 1.0 0.0 X 0 0 0 Gibson Nancy Trustee 1.0 0.0 X 0 0 0 Greenthal Jill Trustee 1.0 0.0 X 0 0 0 Gross Phillip Trustee 1.0 0.0 X 0 0 0 Hadley Christopher Trustee 1.0 0.0 X 0 0 0 Harkins David Trustee 1.0 0.0 X 0 0 0 Heller Frances Trustee 1.0 0.0 X 0 0 0 Jamieson Jane Trustee 1.0 0.0 X 0 0 0 Janower Andrew Trustee 1.0 0.0 X 0 0 0 Kafker Hon Scott Trustee 1.0 0.0 X 0 0 0 Kelley Joesph Trustee 1.0 0.0 X 0 0 0 Knez Brian Trustee & Treasurer 2.0 0.0 X X 0 0 0 Koppel Steven Trustee 1.0 0.0 X 0 0 0 Koster Stephen ESQ Trustee 1.0 0.0 X 0 0 0 Kraft Robert Trustee 1.0 0.0 X 0 0 0 Kyle Amy Trustee 1.0 0.0 X 0 0 0 LaTorre James Trustee 1.0 0.0 X 0 0 0 Lubin Richard Trustee & Vice-Chairman 2.0 0.0 X X 0 0 0 Lucas Bradley Trustee 1.0 0.0 X 0 0 0 Lucchino Lawrence Trustee 1.0 0.0 X 0 0 0 Marcus Paul Trustee 1.0 0.0 X 0 0 0 Martin Demond Trustee 1.0 0.0 X 0 0 0 Norberg Joesph Trustee 1.0 0.0 X 0 0 0 O'Connor John Trustee 1.0 0.0 X 0 0 0 Owens Edward Trustee 1.0 0.0 X 0 0 0 Packman Karen Linde Trustee 1.0 0.0 X 0 0 0 Palandjian Peter Trustee 1.0 0.0 X 0 0 0 Pasquarello Theodore Trustee 1.0 0.0 X 0 0 0 Perini Jennifer Trustee 1.0 0.0 X 0 0 0 Perlmutter Steven ESQ Trustee 1.0 0.0 X 0 0 0 Poduska Susan Trustee 1.0 0.0 X 0 0 0 Pohl Elizabeth Trustee 1.0 0.0 X 0 0 0 Reynolds Robert Trustee 1.0 0.0 X 0 0 0 Rosenthal Harvey Trustee 1.0 0.0 X 0 0 0 Sachs Robert ESQ Trustee 1.0 0.0 X 0 0 0 Salter Malcolm Trustee 1.0 0.0 X 0 0 0 Sanders Rebecca Trustee 1.0 0.0 X 0 0 0 Schlager Eric Trustee 1.0 0.0 X 0 0 0 Sen Laura Trustee 1.0 0.0 X 0 0 0 Socol Jerry Trustee 1.0 0.0 X 0 0 0 Stansky Robert Trustee 1.0 0.0 X 0 0 0 Sullivan Ronald Trustee 1.0 0.0 X 0 0 0 Tempel Jean Trustee 1.0 0.0 X 0 0 0 Terrana Beth Trustee 1.0 0.0 X 0 0 0 Ting David Trustee 1.0 0.0 X 0 0 0 Williams Frederica Trustee 1.0 0.0 X 0 0 0 Yost George Trustee 1.0 0.0 X 0 0 0 Bird Karen CFO & Asst. Treasurer 50.0 0.0 X 477913 0 67681 Boskey Richard S ESQ Asst. Sec. & General Counsel 50.0 0.0 X 551377 0 67289 Puhy Dorothy COO & EVP 50.0 0.0 X 817437 0 43539 Bartel Sylvia RPh MHP VP of Pharmacy Services 50.0 0.0 X 231952 0 58605 Bunnell Craig A MD Chief Medical Officer 50.0 0.0 X 495786 0 44585 Gettleman Wendy VP of Facilities Management 50.0 0.0 X 235430 0 57361 Griffin James D MD Chair of Medical Oncology 50.0 0.0 X 674922 0 60570 Johnson Bruce MD Chief Clinical Research Office 50.0 0.0 X 558016 0 73344 Megdal Maria SVP of Institute Operations 50.0 0.0 X 401217 0 50318 Memmott Drew SVP Research Administration 50.0 0.0 X 388168 0 18413 Paresky Susan SVP of Development 50.0 0.0 X 624365 0 59915 Rollins Barrett J MD PHD Chief Scientific Officer 50.0 0.0 X 636525 0 51607 Shulman Lawrence N MD Chief of Medical Staff-Retired 50.0 0.0 X 705037 0 57026 Stone Richard M MD Chief of Medical Staff 50.0 0.0 X 431482 0 71709 Constantine Michael MD Milford Med Dir-Hematology Onc 50.0 0.0 X 689648 0 49404 Kantoff Philip MD Chief Clinical Research Office 50.0 0.0 X 613019 0 66385 Nadler Lee MD SVP for Experimental Medicine 50.0 0.0 X 670036 0 61848 Soiffer Robert J MD Chief of Hemotologic Malignanc 50.0 0.0 X 565641 0 68821 Winer Eric MD Chief of Div of Women's Cancer 50.0 0.0 X 653327 0 76872 Orkin Stuart Former Officer 50.0 0.0 X 135167 0 5093 Herring Tom Former Key Employee 50.0 0.0 X 137768 0 30866 Reid-Ponte Pat Former Key Employee 50.0 0.0 X 430527 0 52273 Sallan Stephen E MD Former Key Employee 50.0 0.0 X 515216 0 59833 12801572 136551 1494999 875 true true false John Moriarty Associates Inc 3 Church St 2 WINCHESTER MA 01890 Construction Service 38966297 Partners Healthcare System Inc PO Box 3715 BOSTON MA 02241 Information Systems 73483482 Brigham and Women's Physicians Org 111 Cypress Street BROOKLINE MA 02445 Medical Services 13252917 Harvard University 1350 Massachusetts Ave CAMBRIDGE MA 02138 Research Services 13899589 The Brigham and Women's Hospital 75 Francis Street BOSTON MA 02115 Medical Services 43478869 417 342208 23605561 127714307 276221227 12138464 427883303 NET PATIENT SERVICE REVENUE 621110 746516458 746516458 746516458 261256 261256 0 11604292 11604292 5433505 5433505 0 5433505 5433505 0 764353 23605561 2753909 -1989556 -1989556 0 0 PARKING LOT REVENUE 812930 5460028 5460028 FOOD SERVICE REVENUE 722210 3941331 3941331 WCP BOUTIQUE INCOME 446199 1140461 1140461 3039066 3039066 13580886 1203290144 746516458 28890383 1376684 1376684 943995 943995 0 0 9197311 4214540 4304528 678243 0 327611777 248006120 64124844 15480813 20829863 15620068 4216306 993489 27267588 20447642 5519408 1300538 23450063 17584925 4746678 1118460 6496569 1781763 4714806 5530838 4513336 992218 25284 507446 507446 242280 242280 4081039 4081039 0 145638054 117452257 28034988 150809 4657608 1034329 2831830 791449 29384254 17728274 11105049 550931 43137319 13004307 30113783 19229 0 84587517 69684588 14898295 4634 7688529 2250607 5383085 54837 0 4579811 1230154 2732860 616797 13818908 13818908 0 72080449 58790728 13289721 5479581 3182964 2296617 OTHER PATIENT CARE EXPENSES 23564951 23564951 MISCELLANEOUS 24811208 20633473 3896350 281385 MEDICAL SUPPLIES EXPENSE 274432522 274432522 BAD DEBT EXPENSE 7454873 7454873 1168851037 938994288 203708812 26147937 0 0 298937 16444485 60980093 63379774 102232434 110746401 1047696 1073650 0 0 0 0 15517529 14995013 20217077 19695529 1404128280 657962862 692589474 746165418 0 0 0 0 0 0 7894580 7894580 1049408550 1033937515 1950186370 2014332365 101527511 145700600 0 0 0 0 276408738 272712859 0 0 0 0 82808737 81018005 0 0 176490463 202557252 637235449 701988716 X 607664709 620620003 538069716 516904112 167216496 174819534 1312950921 1312343649 1950186370 2014332365 X 34439107 -35046379 X false true X true true true X 440670897 398632881 393393949 403408212 427883303 2063989242 0 0 440670897 398632881 393393949 403408212 427883303 2063989242 0 2063989242 12603828 10185220 12285983 30943986 17299053 83318070 1147 1147 10965879 11866982 14090598 15163484 14345239 66432182 2213740641 3202273140 0.93235 0.93337 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED true true false true false true 242280 true 39963 false false 282243 false Schedule C Part II-B O'NEILL, ATHY & CASEY, P.C. - provided federal legislative and government relations consulting services to the Conference of Boston Teaching Hospitals, of which we are a member. VAN SCOYOC - provided federal legislative consulting to DFCI. MCDERMOTT, QUILTY & MILLER, LLP - provided state legislative and government relations consulting on health interests to DFCI. CONFERENCE OF BOSTON TEACHING HOSPITALS PROVIDED STATE AND FEDERAL LOBBYING SUPPORT TO DFCI. DFCI IS A MEMBER OF THE AMERICAN HOSPITAL ASSOCIATION AND THE MASSACHUSETTS HOSPITAL ASSOCIATION, NOT-FOR-PROFIT ORGANIZATIONS THAT REPRESENT AND ADVOCATE FOR THE COLLECTIVE INTERESTS OF THEIR MEMBER HOSPITALS AND HEALTH SYSTEMS THROUGH LEADERSHIP IN PUBLIC ADVOCACY, EDUCATION, AND INFORMATION. A PORTION OF THE MEMBERSHIP DUES TO THESE ORGANIZATIONS ARE USED FOR LOBBYING ACTIVITIES. On occasion, DFCI executive leadership meet with state and federal elected officials to advocate for the passage of legislation and funding to advance cancer research and treatment, and legislation to support services for cancer patients and cancer survivors. 1743171 X false 250650000 7603000 -4102000 15702000 238449000 231119000 11556000 22937000 14962000 250650000 207975000 9214000 27582000 13652000 231119000 187242000 9879000 22169000 11315000 207975000 179577000 9098000 8614000 10047000 187242000 0.73000 0.27000 false true true 7640455 7640445 827540113 337406694 490133419 152342349 81671158 70671191 394215805 238885010 155330795 22389568 22389568 746165418 INTEREST IN DANA-FARBER, INC. 963288515 MISCELLANEOUS ASSETS 54719000 INTEREST IN DFCCN 15930000 1033937515 0 AMOUNTS DUE TO 3RD PARTY PAYOR 60044726 RESEARCH ADVANCES 50566000 PROV FOR MED MALPRACTICE CLAIM 1362000 SWAP VALUATION LIABILITY 48416000 MISCELLANEOUS LIABILITIES 42168526 202557252 SCHEDULE D PART III, QUESTION 4 Central America and the Caribbean Program Services Subcontracted Research 70298 Central America and the Caribbean Program Services Jointly Owned for Ins 3123982 East Asia and the Pacific Program Services Subcontracted Research 661550 Europe (Including Iceland and Greenland) Program Services Subcontracted Research 2080360 Middle East and North Africa Program Services Subcontracted Research 25000 North America Program Services Subcontracted Research 523793 South America Program Services Subcontracted Research 25715 South Asia Program Services Subcontracted Research 1178373 Central America and the Caribbean Program Services Research and Education 43094 East Asia and Pacific Program Services Research and Education 527575 North America Program Services Research and Education 7692 South America Program Services Research and Educaiton 511329 8778761 8778761 true false true false false false X X X X X X X true STRATEGIC FUNDRAISING telefundrai consulting false 229283 191010 37293 TRUESENSE MARKETING Direct Mail Consultant false 11086875 3890029 7196846 11316158 4081039 7234139 All States BMFJ Walk 8246000 8056268 189732 18717 7105 899276 MarathonChallan 5493595 5301795 191800 45494 10368 413099 14 10630319 10247498 382821 43234 2272 1314344 24369914 23605561 764353 107445 19745 2626719 2753909 -1989556 true true X true X 133. true X true true false true true 12078153 6470998 5607155 0.00480 40666473 32269046 8397427 0.00720 52744626 38740044 14004582 0.01200 3511743 3511743 0.00300 5279768 475779 4803989 0.00410 255771913 229597502 26174411 0.02260 1154988 1154988 0.00100 265718412 230073281 35645131 0.03070 318463038 268813325 49649713 0.04270 655526 655526 0.00060 391000 391000 0.00030 1046526 1046526 0.00090 true 6660326 66603 156399041 172080109 -15681068 true true 1 1 DANA-FARBER CANCER INSTITUTE INC 450 BROOKLINE AVE BOSTON MA 02215 www.dana-farber.org X X X D-F/BWH @ Milford, and SOUTH Shore D-F @ st elizabeth's DANA-FARBER CANCER INSTITUTE INC 1 false false true X X X X X X X X X 12 true false false true X dana-farber.org X true 12 true dana-farber.org false false true X 133. 300. X true true X true X dana-farber.org X dana-farber.org X dana-farber.org X X X X X true X false X X X true X false false Part V Part V, Line 5 The DFCI's Community Benefits Office partnered with Health Resources in Action (HRiA), a non-profit public health consultancy organization in Boston, to undertake a two phase comprehensive community health assessment. In Phase I, social, economic, and epidemiological data at the community level were reviewed and analyzed to provide a health portrait of DFCI's priority communities (Roxbury, Mission Hill, Dorchester, Mattapan, and Jamaica Plain). Phase II involved a comprehensive qualitative study, where DFCI staff, community leaders, and residents provided feedback in focus groups and interviews to identify community needs and assets as well as areas for further community engagement and program expansion. Focus groups included staff members from the following community organizations: Roxbury Tenants, Boston Public Health Commission, Roxbury Comprehensive Health Center, Boston Asian: Yes, Tobin Community Center, Mission Hill Neighborhood Housing Services. In addition, community residents participated in focus groups hosted by Whittier Street Health Center and La Alianza Hispana. Additionally, the Community Benefits External Advisory Committee members and DFCI Trustees Community Programs Committee provided guidance, oversight and input. A total of 86 individuals participated in the Phase II qualitative research in order to gauge their perceptions of their neighborhood, their health concerns, what programming or services are most needed to address these concerns and the role of DFCI in these efforts. Part V, Line 7a DFCI's Community Health Needs Assessment Report is available on the DFCI Website http://www.dana-farber.org/About-Us/Community-Outreach/Community-Health-Ne eds-Assessment-Reporting.aspx Part V, Line 10a DFCI's implementation strategy is available on the DFCI website. http://www.dana-farber.org/uploadedFiles/Library/about-us/community-outrea ch/chna-implementation-plan.pdf Part V, Line 11 Dana-Farber will continue to partner with community organizations to address broader issues that go beyond cancer care, such as those related to healthy eating and physical activity, community strengths, and the social determinants of health such as the Boston Public Health Commission and Boston Alliance for Community Health in addition to our 16 community health center partners. Part V Line 13h Within DFCI's credit and collections policy there are provisions that describe collection practices to be followed for patients who are known to qualify for charity care or financial assistance in accordance with federal and Massachusetts law. Part V Line 16i Shared with community groups Part V Line 22 Depending on a patient's financial situation, FAP-eligible patients were charged between 0% to 30% of billed charges, which was not more than the AGB. In FY15, DFCI determined AGB on an annual basis using the "look-back method," described under Treasury Regulation Section 1.501(r)-5(b)(1). Specifically, DFCI's annual AGB percentage was equal to sum of all gross charges during the prior fiscal year divided by Claims Paid in connection with those charges. For purposes of the AGB calculation, Claims Paid included claims for emergency and medically necessary care paid by both Medicare fee-for-service and all private health insurers as primary payers, together with any associated portions of these claims paid by Medicare beneficiaries or insured individuals in the form of co-payments, co-insurance or deductibles. 1 DANA-FARBERNHOH ELLIOTT MED CENTER 40 BUTTRICK RD LONDONDERRY NH 03053 MED ONCOLOGY & INFUSION UNIT Part I Part I, Line 3c Pursuant to its written policy Dana-Farber Cancer Institute (DFCI) provides financial assistance to patients based on their family income level and in certain cases based on the family's excessive medical expenses relative to family income. In addition, DFCI provides a forty-five (45%) discount to all uninsured patients. Part I, Line 6a The community benefit report was completed by DFCI and is annually provided to the Massachusetts Attorney General's office, where it is then made public on their website. Part I, Line 7 DFCI's internal cost accounting system, which accounts for all Institute activity, was used to create the cost to charge ratio that was applied to charity care charges to determine the financial assistance cost (Line 7a). Line 7f reflects the costs of education, as calculated on the Medicare cost report, less any applicable reimbursement received for it. Part I Line 7h DFCI devoted $110,809,998 of funds from individual gifts and commercial agreements, which are not includable in line 7h, to further its research mission of staking out new territory in the fight against cancer, from advancing the understanding of the genetic makeup of cancer cells to developing novel therapies to diagnose, treat, and prevent the disease. Part I Line 7h Column d DFCI's 2015 Direct Offsetting Research Revenue includes $221,067,656 of restricted grants received by the Institute to further its research mission. Part II Part II, Line 1 Physical Improvements and housing-DFCI provides a limited number of low cost rooms that serve as a home away from home for oncology patients and their families while they are receiving treatment. Part II, Line 8 Diversity and Workforce Development: In collaboration with nearby health care institutions, DFCI offers English as a Second Language (ESL) classes to staff, Business Writing for Professionals is an onsite 6-month college prep course designed to help front-line employees enhance reading and writing skills necessary for success in the workplace and in the classroom. DFCI also continued its collaboration with The Partnership to train and to increase the number of people of color in leadership roles in the Boston community. DFCI has continued its collaboration with the YMCA Achievers Program to recognize employees of color for their accomplishments and demonstrated excellence in their profession. Part III Part III, Line 3 The amount of Bad Debt attributed to financial assistance patients is based on actual writeoffs. The Bad Debt amount should be treated as a community benefit as it is similar to Unreimbursed Financial Assistance, as reported and allowed (Part I Line 7a), but for a different population. Part III, Lines 2 and 4 There is no footnote in the Audited Financial Statements that describes Bad Debt. The amount of Bad Debt expense on Line 2 $6,660,326 is from our general ledger and is based on the treatment of Bad Debt activity consistent with Generally Accepted Accounting Principles (GAAP). Part III, Line 8 The Medicare allowable costs of $172,080,109 come directly from the Medicare cost report and are based on Medicare's cost finding principles and methodologies. We strongly believe that the entire amount of the shortfall $15,681,068 should be treated as a community benefit, as this represents the Institute's commitment to the elderly and disabled community by providing services that are not reimbursed. Part III, Line 9b Within DFCI's credit and collections policy there are provisions that describe collection practices to be followed for patients who are known to qualify for charity care or financial assistance in accordance with federal and Massachusetts law. Part V Part V, Section A DFCI main campus is at 450 Brookline Ave., Boston, MA. Its following satellite locations (below) each operate under the same hospital license. Dana-Farber/Brigham and Women's Cancer Center at Milford Hospital 20 Prospect Street, Milford, MA 01757 Dana-Farber/Brigham and Women's Cancer Center at South Shore Hospital 101 Columbian Street, South Weymouth, MA 02190 Dana-Farber at St. Elizabeth's Medical Center 736 Cambridge Street, Cushing Pavilion, 5th Floor, Brighton MA 02135 Part VI Part VI, Line 2 - Needs Assessment The DFCI's Community Benefits Office partnered with Health Resources in Action (HRiA), a non-profit public health consultancy organization in Boston, to undertake a two phase comprehensive community health assessment. In Phase I, social, economic, and epidemiological data at the community level were reviewed and analyzed to provide a health portrait of DFCI's priority communities (Roxbury, Mission Hill, Dorchester, Mattapan, and Jamaica Plain). Phase II involved a comprehensive qualitative study, where DFCI staff, community leaders, and residents provided feedback in focus groups and interviews to identify community needs and assets as well as areas for further community engagement and program expansion. Focus groups included staff members from the following community organizations: Roxbury Tenants, Boston Public Health Commission, Roxbury Comprehensive Health Center, Boston Asian: Yes, Tobin Community Center, Mission Hill Neighborhood Housing Services. In addition, community residents participated in focus groups hosted by Whittier Street Health Center and La Alianza Hispana. Additionally, the Community Benefits External Advisory Committee members and DFCI Trustees Community Programs Committee provided guidance, oversight and input. Over this 3 year period, DFCI staff have continued to participate in local coalitions that seek to improve the health status of neighborhood residents. In partnership with these Coalitions, DFCI will continue to develop cancer prevention programs to meet the unique needs of these communities. An enhanced program evaluation protocol was developed in FY 13 using the Redcap database to generate program evaluation reports. Part VI, Line 3 - Patient Education of Eligibility for Assistance DFCI recognizes that some patients will not be able to pay for services rendered and may not be aware of the availability of available assistance. The Institute will also notify the patient about available DFCI financial assistance and payment plans that may be available to them. For those patients who are uninsured or underinsured, the Institute may assist patients in applying for coverage of services within a financial assistance program to cover some or all of their unpaid hospital bills, such as Mass Health, Care plus, Connector Care, Qualified Health Plan (QHP), Children's Medical Security Plan, Healthy Start, Health Safety Net, as well as a Medical Hardship discount based on the patient's documented income and allowable medical expenses. The Institute will provide, upon request, specific information about the eligibility process to be a Low Income Patient under the Massachusetts Health Safety Net Program. The Institute posts signs regarding the availability of financial assistance in each registration office. Posted signs are clearly visible and legible to patients visiting these areas. The posted signs are poster size 12' by 18', font size , in English and Spanish. The Institute provides patients with information about financial assistance with each bill it sends to patients and in phone conversations with patients regarding bills. Part VI, Line 4 - Community Information DFCI's focuses its community outreach efforts on its priority Boston neighborhoods of Roxbury, Mission Hill, Dorchester, Mattapan and Jamaica Plain (which collectively comprise 38% of Boston's overall population). According to the 2005-2009 American Community Survey, in Mattapan and Roxbury/Mission Hill, 87.8% and 53.1% of residents respectively identified themselves as Black. Approximately one-quarter of residents in Roxbury/Mission Hill (22.5%) and Jamaica Plain (20.9%) identified themselves as Latino. Census data show that in Roxbury/Mission Hill, 40.5% of individuals live in poverty, as do 39.4% of individuals in Mattapan. Part VI, Line 5 - Promotion of Community Health Community outreach at DFCI focuses on increasing awareness about the importance of cancer prevention, outreach, screening, early detection and clinical trials education. Examples of prevention programs are: 1. DFCI's Mammography Van (DFMV) Dana-Farber's Mammography Van was launched as a joint venture between the City of Boston and Dana-Farber in April 2002. The Mammography Van continues to be the only mobile mammography program in the Commonwealth of Massachusetts. It provides digital screening mammograms and breast health education to women 40 years of age and older. Ultimately, it aims to decrease breast cancer morbidity and mortality among medically underserved women and increase survival rates for those diagnosed with breast cancer. Priority populations include women who are low-income, elderly, immigrant, non-English speaking, people of color, and other minority backgrounds. Priority neighborhoods in Boston include Roxbury, Jamaica Plain and Dorchester. In partnership with 15 community-based organizations and neighborhood health centers such as The Dimock Center and Charles River Community Health Center, the Van is on the road 3-4 days per week year-round. The mammogram on the van is treated as a point of entry into the larger health care system. Women who lack a primary care provider are referred to one of our partner neighborhood health centers for assistance in acquiring health services including health insurance enrollment and an appointment with a primary care provider. Dana-Farber's Mammography Van provides an effective way for women to continually monitor their breast health and to stay connected to the health care system at large. Building on their shared commitment to caring for community residents, Dana-Farber opened a mammography suite within the Whittier Street Health Center, located in Boston's Roxbury neighborhood in 2013. Open to all residents, the mammography suite, situated on the clinic's first floor, is staffed with skilled, registered mammography technologists and additional members of the care team focused on reducing health care disparities. The suite uses digital mammography imaging, which is interpreted by board-certified radiologists with extensive experience in mammography. In FY15, 831 mammograms were provided to women. Individual education at mammography screening sites has been shown to improve adherence to annual screening. To that end, the Mammography Van program employs a breast health educator who is available on site to provide information and answer questions about early detection, healthy lifestyle choices to reduce cancer risk, and timely follow up. Additionally, the educator helps to increase awareness of Dana-Farber's Mammography Van in the community by working with current and potential community partners to provide residents with breast health information and mammography referrals at health fairs and educational workshops. In FY15, there were over 1200 breast health outreach contacts and more than 40 women were referred for screening mammograms as a result of community outreach efforts. In FY15, Dana-Farber's Mammography Van provided 2,062 mammograms. Since program inception in April 2002, Dana- Farber's Mammography Van has provided more than 41,000 mammograms to more than 18,000 unique patients. The largest racial and ethnic groups seen on the van are Black and Latino. This year, approximately 27% of van patients self-identified as being Black; 18% as Hispanic/Latino background and almost 7% as Asian. Over the past year, 51% of van patients spoke a first language other than English. Dana-Farber's Mammography Van patients speak 24 different languages. The top primary languages after English are: Spanish; Cape Verdean Creole; Portuguese; Vietnamese and Haitian Creole. 66.3% of patients screened on the van were returnees from prior years; 33.4% of van patients returned for re-screening in a "timely" manner (10-18 months from last screen). 12.9% of van patients served this year had their baseline (first-ever) mammograms on the van. 258 patients (12.5%) screened on the van in the past year received a recommendation for follow-up. Over the past year, the insurance status of van patients was: less than 1% uninsured; 63.8% publicly insured (Medicare, MassHealth, Health Safety Net, etc); and 35.9% privately insured. 2. HPV and Cervical Cancer Pilot Education Program The most recent Community Health Needs Assessment found that cervical cancer mortality rates are higher among Black and Latino minorities in Boston. To address these findings, Community Benefits partnered with Team Maureen, a non-profit organization whose mission is to raise awareness about HPV and cervical cancer. Massachusetts still lags far behind the Healthy People 2020 goal of 80% completion, at 40% and 21% for females and males respectively. Medically underserved communities have lower HPV immunization completion rates. The goal of the partnership is to combine efforts to reach the Healthy People 2020 goal of 80% HPV vaccination rate among adolescents regardless of race/ethnicity or socioeconomic status. DFCI's HPV and Associated Cancer true AMERICAN CANCER SOCIETYTOBACCO FREE MA 250 Williams ST NW Atlanta GA 30303 131788491 501(C)(3) 11000 CANCER RES AND DEVLP FENWAY HIGH SCHOOL 174 Ipswich Street Boston MA 02215 046719813 501(C)(3) 20000 community support Friend's of Dana-Farber 450 Brookline Ave BOSTON MA 02215 371613621 501(C)(3) 50000 CANCER RES and devlp LEUKEMIA & LYMPHOMA SOCIETY 1311 Mamaroneck Ave Suite 310 White Plains NY 10605 135644916 501(C)(3) 40000 CANCER REs and devlp LUNG CANCER ALLIANCE 888 16th Street NW No 150 Washington DC 20006 911821040 501(C)(3) 10000 CANCER RES and devlp MADISON PARK DEVELOPMENT CORPORATION 184 Dudley St Roxbury MA 02119 237164223 501(C)(3) 10000 community support PROSTATE HEALTH EDUCATION NETWORK INC 500 Victory Rd 4th Fl Quincy MA 02453 331042404 501(C)(3) 30000 CANCER RES and devlp THE BREAST CANCER RESEARCH FOUNDATION 60 East 56th Street 8th FL New York NY 10022 133727250 501(C)(3) 15000 Cancer Res and devlp UNITED WAY OF MASSACHUSETTS BAY 51 Sleeper St Boston MA 02210 042382233 501(C)(3) 20000 Cancer Res and devlp WHITTIER STREET HEALTH CENTER 1290 Tremont St Roxbury MA 02120 042619517 501(C)(3) 144770 Cancer Res and devlp Harvard University 60 Oxford Street Cambridge MA 02138 042103580 501(c)(3) 808533 Cancer Res and devlp Boston Children's Hospital 300 Longwood Ave Boston MA 02115 042774441 501(c)(3) 34375 Cancer Res and devlp Edward M Kennedy Institute 210 Morressey Boulevard Boston MA 02125 270963869 501(c)(3) 25000 community support Boston Private Industry Council 2 Oliver St Boston MA 02109 042676661 501(c)(3) 10000 community support Boston Ronald McDonald House 229 Kent St Brookline MA 02446 042627411 501(c)(3) 6000 Cancer Res and devlp Youth Enrichment Services 412 Massachusetts Avenue Boston MA 02118 042509466 501(c)(3) 5250 community support 16 0 Patient Assistance 108 77320 Patient Assistance 1064 866675 FMV Patient supt Part IV All grants and donations were given to 501(c)(3) organizations to fulfill their missions. X false true X X X X X false true false false false false false true false Benz Edward J Jr MD Trustee, President and CEO 773789 136551 288424 0 99383 0 220921 0 20721 0 1403238 136551 0 0 Bird Karen CFO & Asst. Treasurer 404750 0 62320 0 10843 0 37050 0 30631 0 545594 0 0 0 Boskey Richard S ESQ Asst. Sec. & General Counsel 459235 0 72750 0 19392 0 37050 0 30239 0 618666 0 0 0 Puhy Dorothy COO & EVP 621150 0 147600 0 48687 0 37050 0 6489 0 860976 0 0 0 Bartel Sylvia RPh MHP VP of Pharmacy Services 220747 0 18763 0 -7558 0 30573 0 28032 0 290557 0 0 0 Bunnell Craig A MD Chief Medical Officer 414100 0 65600 0 16086 0 37050 0 7535 0 540371 0 0 0 Gettleman Wendy VP of Facilities Management 219300 0 23641 0 -7511 0 30335 0 27026 0 292791 0 0 0 Griffin James D MD Chair of Medical Oncology 550364 0 87186 0 37372 0 37050 0 23520 0 735492 0 0 0 Johnson Bruce MD Chief Clinical Research Office 474700 0 43867 0 39449 0 55288 0 18056 0 631360 0 0 0 Megdal Maria SVP of Institute Operations 340000 0 52000 0 9217 0 37050 0 13268 0 451535 0 0 0 Memmott Drew SVP Research Administration 274816 0 75000 0 38352 0 0 0 18413 0 406581 0 0 0 Paresky Susan SVP of Development 511188 0 80980 0 32197 0 37050 0 22865 0 684280 0 0 0 Rollins Barrett J MD PHD Chief Scientific Officer 522064 0 82703 0 31758 0 37050 0 14557 0 688132 0 0 0 Shulman Lawrence N MD Chief of Medical Staff-Retired 573827 0 90903 0 40307 0 37050 0 19976 0 762063 0 0 0 Stone Richard M MD Chief of Medical Staff 388219 0 34178 0 9085 0 37050 0 34659 0 503191 0 0 0 Constantine Michael MD Milford Med Dir-Hematology Onc 565596 0 89226 0 34826 0 24050 0 25354 0 739052 0 0 0 Kantoff Philip MD Chief Clinical Research Office 499572 0 79140 0 34307 0 37050 0 29335 0 679404 0 0 0 Nadler Lee MD SVP for Experimental Medicine 547091 0 86668 0 36277 0 37050 0 24798 0 731884 0 0 0 Soiffer Robert J MD Chief of Hemotologic Malignanc 499541 0 39149 0 26951 0 37050 0 31771 0 634462 0 0 0 Winer Eric MD Chief of Div of Women's Cancer 486567 0 77080 0 89680 0 42050 0 34822 0 730199 0 0 0 Herring Tom Former Key Employee 144500 0 5000 0 -11732 0 10768 0 20098 0 168634 0 0 0 Orkin Stuart Former Officer 133333 0 0 0 1834 0 4650 0 443 0 140260 0 0 0 Reid-Ponte Pat Former Key Employee 362337 0 57400 0 10790 0 37050 0 15223 0 482800 0 0 0 Sallan Stephen E MD Former Key Employee 428084 0 68093 0 19039 0 37050 0 22783 0 575049 0 0 0 Schedule J, Part 1, Line 4b The following individuals participate in DFCI's 457(f) plan; taxable amounts are included in reportable compensation in Schedule J, Part II, Column (B)(iii): Benz, Edward J. Jr., MD 81,292 Bird, Karen 18,094 Boskey, Richard S., ESQ 24,904 Puhy, Dorothy 45,144 Bunnell, Craig A. MD 19,263 Griffin, James D., MD 36,296 Johnson, Bruce MD 26,838 Megdal, Maria 10,000 Paresky, Susan 31,399 Rollins, Barrett J., MD, PHD 32,758 Shulman, Lawrence N., MD 39,228 Stone, Richard M MD 16,027 Constantine, Michael, MD 38,200 Kantoff, Philip MD 29,947 Nadler, Lee, MD 35,886 Soiffer, Robert J., MD 29,943 Winer, Eric, MD 28,321 Reid-Ponte, Pat 12,792 Sallan, Stephen E., MD 21,011 Part I Question 7 During the year, the CEO, COO, CFO, General Counsel, and the Key Employees were eligible to receive an incentive payment, a portion of which was a non-fixed payment payable at the discretion of the CEO and in the case of the CEO, the Compensation Committee, if the organization meets certain financial performance goals. The maximum possible non-fixed portion of these incentive payments ranged from 8% to 4% of base salary. A Massachusetts Development Finance Agency 042456011 57586CZ24 2008-05-22 296490068 See Part VI false false false B Massachusetts Development Finance Agency 043431814 2012-07-02 57500000 See Part VI false false false C Massachusetts Development Finance Agency 043431814 2015-08-03 92500000 See Part VI false false false A 150000000 0 301906298 8253498 4119476 0 2015100 116494 0 90335422 197066308 0 2011 true false true true B 0 0 57500000 0 0 0 0 0 0 0 57500000 0 2012 true false true true C 0 0 92500000 0 0 0 0 0 0 0 92500000 0 2015 true false true true A false false true true true true 0 false false false true B false false true true true true 0 false false false true C false false true true true true 0 false false false true A false false false true true true Morgan Stanley Capit 39.8 false false true Trinity Funding 2.8 true false true B false false false true true true Morgan Stanleu Capit 39.8 false false false 0 false true C false false false true true true Morgan Stanley Capit 39.8 false false false 0 false true A true B true C true Part I (Bond Issues): A (a) Issuer name: Massachusetts Health and Educational Facilities Authority, succeeded by Massachusetts Development Finance Agency A (f) Description of purpose: The bond issue was used to refund Pool J-1 issued on June 30, 1993; Pool J-2 issued on June 8, 1995;Pool M-2 issued on May 30, 2002; Series H issued on May 4, 2004; Series I issued on February 8, 2007 and to partially finance the construction of the Yawkey Center for Cancer Care. B (f) Description of purpose: The bond issue was used to refund part of Series L-2 bonds issued on 5/22/2008. C(f) Description of purpose: the bond issue was used to fefund Series L-1 bonds issued on 5/22/2008 C(f) Description of purpose: the bond issue was used to fefund Series L-1 bonds issued on 5/22/2008 Part IV (Arbitrage): A2(c) Did the following apply "No rebate due" - rebate calculation was performed in October 2015 B2(c) Did the following apply "No rebate due" - rebate calculation was performed in October 2015 C2(c)Did the following apply "No rebate due" - rebate calculation was performed in October 2015 A4(b) Name of provider: Morgan Stanley Capital Services, Inc. B4(b) Name of provider: Morgan Stanley Capital Services, Inc. C4(b) Name of provider: Morgan Stanley Capital Services, Inc. A5(b) Name of provider: Trinity Funding Company, LLC Patricia Ponte Tuition Assistance X 117395 10695 false true true Stephen Sallan Tuition Assistance X 262081 75793 false true true Bruce Johnson Housing Loan X 400000 68333 false true true Edward Benz Housing Loan X 600000 301666 false true true Karen Bird Tuition Assistance X 49550 30586 false true true Drew Memmott Housing Loan X 75000 65625 false true true 552698 oncopep See Part V see Part V false acetylon See Part V see Part v false haringen llc See Part V 129596 See part V false The risk management foundationrmf See Part V 3123982 See part V false berkshire partners See Part V 1224240 See Part V false charlesbank capital partners See Part V 1678065 See Part V false Part IV Oncopep: DFCI Trustee Marc Cohen and the spouse of DFCI Trustee Sean Dobson are on the board of and own stock in Oncopep. Theodore Pasquarello, also a DFCI Trustee, owns stock in Oncopep. Dana-Farber licensed technology to Oncopep and received shares in Oncopep in exchange for the license. Eventually DFCI could receive royalty payments from Oncopep. Acetylon: DFCI Trustee Marc Cohen is the Chairman of the Board of Acetylon Pharmaceuticals. Marc Cohn, Sean Dobson, Robert Kraft, Rebecca Sanders, all DFCI Trustees, own directly or indirectly interests in Acetylon Pharmaceuticals. Dana-Farber licensed technology to Acetylon and received shares in Acetylon in exchange for the license. Eventually DFCI could receive royalty payments from Acetylon. Tom Herring, a Former Key Employee of DFCI is the Managing Partner of Haringen, LLC. During FY15, DFCI paid $129,596 in consulting fees to Haringen, LLC. DFCI paid $3,123,982 to The Risk Management Foundation of the Harvard Medical Institutions Incorporated (RMF) for professional and organizational liability insurance. DFCI Executive Vice President and Chief Operating Officer Dorothy Puhy is a member of the governing board of RMF. Dorothy Puhy is also a Director of Controlled Risk Insurance Company, Ltd (CRICO). Dana-Farber, Inc. (DFI), an organization related to DFCI, holds interests, through an investment pool, in alternative investments managed by Berkshire Partners. During FY15, DFI transferred approximately $1,224,240 into these investments. Dana-Farber Trustees Richard Lubin and Christopher Hadley are Managing Directors of Berkshire Partners. Dana-Farber, Inc. (DFI), an organization controlled by DFCI, holds interests in investments managed by Charlesbank Capital Partners. During FY15, DFI transferred approximately $1,678,065 into these investments. Dana-Farber Trustee Andrew Janower is a Managing Director of Charlesbank Capital Partners. X 755640 Letter from Donor X 232 10345208 Fair Market Value X 27 303534 Letter from Donor X Miscellaneous 30 734082 Letter from Donor false true true Schedule M, Part I, Line 33 DFCI received donations of art, books, and other goods that it displays in its properties. These goods have values that are either nominal or are not readily determinable, and are therefore not included as revenue. Schedule M, Part I, Line 32b UBS is the broker for stock contributions, they immediately sell any contributed stock. Part VI, Question 2 Family Relationship: John O'Connor and Laura Sen BUSINESS RELATIONSHIP: Richard Lubin and Christopher Hadley (Managing Directors of Berkshire Partners) Part VI, Question 11 Process used to review the Form 990 The Form 990 is prepared by the Tax Department and independently reviewed by Ernst & Young, LLP for technical tax issues. After the Tax Department and Ernst & Young, LLP finalizes the returns, The Chief Financial Officer of the Organization meets with the Tax Department to review the tax return. If any changes need to be made, the Tax Department will make the changes in accordance with the CFO. After the CFO approves the return, certain sections are taken to Board Committees for a more detailed analysis. For example, the Board Compensation Committee reviews all information related to compensation in Part VII and Schedule J. Once the return has been through the committees who review certain sections, the tax return is presented to the Audit Committee for review and approval. After the audit committee approves the tax return, an electronic message is sent to all Board members with a secured link to the tax return. The Board has the opportunity to review the return and if any issues arise, they can bring them to the appropriate executive management individuals. A final version of the form is made available to the Board before filing with the IRS. The return is only filed after each of the steps in the review process is complete. Part VI, Question 12c Monitoring & Enforcement of Conflict of Interest Policy. The Office of General Counsel, the Assistant Secretary of the Board, and the Tax Department drafts a Conflict of Interest Disclosure Questionnaire each year and has all trustees, officers, and key employees fill out a questionnaire in regards to their personal situation and personal and business relationships. The Assistant Secretary compiles the list of Disclosures and gathers financial data from the Accounts Payable and Payroll Department for all organizations, employees, independent contractors, and other miscellaneous transactions which were disclosed by all individuals. Once all of this information is compiled, the Office of General Counsel and the Tax Department goes through each transaction and disclosure to determine what needs to be disclosed on the tax return. The Tax Department and the Office of General Counsel also discusses if there are any other known transactions that have not been disclosed. If there are any questions regarding such situation, the Office of General Counsel and the Assistant Secretary will discuss the questions with the individual trustees, oficers and key employees involved. In addition the process described above, the governance committee of the board of directors annually reviews any new conflict of interest disclosures and they address any issues that may arise. The governance committee is also responsible to bring any major issues related to the conflict of interest policy to the executive committee and the entire Board if deemed necessary. Per DFCI's conflict of interest policy, in order to avoid a conflict of interest or an appearance of a conflict of interest: 1. A Trustee should not participate in a vote on a transaction in which the Trustee or family member has a financial interest and should disclose any potential conflict before DFCI acts on the transaction. 2. A Trustee, a member of his or her family, or an entity with which one or more of them has a material interest, may not do business with DFCI unless expressly authorized by DFCI after full disclosure. 3. A Trustee should fully disclose his or her association (including employment, consulting, or membership on a governing board by the Trustee or a family member) with an entity that competes with or has interests conflicting with those of DFCI and should refrain from participating in any vote if the vote affects DFCI. Once a disclosure has been made, DFCI's Office of General Counsel reviews such conflict and may discuss the matter with the appropriate parties. The Office of General Counsel will then review the matter with the Chairman of the Board. Final decisions are made with the chairman and possibly the Board's Executive Committee. Part VI, Question 15a Process for determining compensation of President Per DFCI's Executive Compensation Philosophy, annually the Compensation Committee of the Board of Trustees reviews the President's (DFCI's Chief Executive Officer) performance and makes a recommendation regarding compensation to the Executive Committee. The Executive Committee acts on the recommendation. To determine the recommendation and to ensure compliance with the Philosophy, the Compensation Committee bi-annually commissions an independent review by a third party organization to compare such compensation with that of other similarly situated individuals in the healthcare field in and outside of the region. The decision of the Executive Committee is reported to the full Board. Annually, following the filing of Form 990s, DFCI compares the information it reports for its President to the compensation of Presidents/CEO's at other area healthcare organizations as well as other institutions that are considered designated comprehensive cancer centers. The Board completed this process as of June 2014. Part VI, Question 15b Process for determining compensation of officers and key employees Per DFCI's Executive Compensation Philosophy, annually the DFCI President reviews the performance of Officers and Key Employees and makes a recommendation as to their compensation to the Compensation Committee of the Board of Trustees. The Compensation Committee establishes compensation for those individuals based on that recommendation. To determine the recommendation and to ensure compliance with the Philosophy, the Compensation Committee bi-annually commissions an independent review by a third party organization to compare such compensation with that of other similarly situated individuals in the healthcare field in and outside of the region. The decision of the Compensation Committee is reported to the Executive Committee of the Board of Trustees and to the full Board. Annually, following the filing of Form 990s DFCI compares the compensation of these individuals with those at other area healthcare organizations as well as other institutions that are considered designated cancer centers. Part VI, Question 19 Availability of Governing Documents, Conflict of Interest Policy, and Financial Statements to the Public We currently provide the governing documents upon request. The Governing Documents are also available to the Public on the Secretary of the Commonwealth's website. Conflict of Interest Policy - DFCI's Conflict of Interest Policy can be found within its Code of Conduct, which is available on its website. Financial Statements - The organization uses the services of Digital Assurance Certification LLC (DAC) to report annual audited financial statements and other relevant organizational information as required by certain regulatory and tax laws. DAC is a website (www.dacbond.com) free to the public that publishes tax-exempt bond issuers' financial and legal documents such as the Audited Financial Statements. Fiscal Year 2001 through the latest issue date of the Audited Financial Statements for Dana-Farber Cancer Institute, Inc. can be found on the DAC website. PART XI LINE 9 OTHER CHANGES IN NET ASSETS CHANGE IN INTEREST IN ASSETS HELD BY AFFILIATE ($18,134,321) CHANGE IN VALUE OF SWAP AGREEMENT $(11,237,561) PENSION ADJUSTMENT $(5,427,000) OTHER CHANGES IN NET ASSETS (247,497) Total Other Changes in Net Assets (35,046,379) FORM 990 PART IX LINE 11G DESCRIPTION:ACCOUNTING FEES FOR SERVICES TOTAL FEES:474000 FORM 990 PART IX LINE 11G DESCRIPTION:OTHER FEES FOR SERVICE TOTAL FEES:XXX-XX-XXXX FORM 990 PART IX LINE 11G DESCRIPTION:PURCHASED RESEARCH SERVICES TOTAL FEES:42256489 Dana-Farber Inc 450 Brookline Avenue BP418 BOSTON MA 02215 043102433 INVEST MGMT MA 501(c)(3) 11A, TYPE 1 DFCI true DANA-FARBER TRUST INC 450 Brookline Avenue BP418 BOSTON MA 02215 300195757 DFCI RE MGMT MA 501(c)(3) 11A DFCI true DANA-FARBERPARTNERS CANCER CARE INC 450 Brookline Avenue BP418 BOSTON MA 02215 043320640 ONCOL SUP ORG MA 501(c)(3) 11c FI DFCI false RMSA TRUST 450 Brookline Avenue BP418 BOSTON MA 02215 562656539 RETRMT TRUST MA 501(c)(9) DFCI true Friends of Dana-Farber Cancer Institute 450 Brookline Ave BP418 Boston MA 02215 371613621 Fundraising MA 501(c)(3) 11A, TYPE 1 DFCI true Dana-FarberChildren's Hospital Cancer C 450 Brookline Ave BP418 Boston MA 02215 043554536 Pediatric Onc MA 501(c)(3) Type 1 N/A Dana-Farber Cancer Care Network Inc 450 Brookline Avenue BP 418 Boston MA 02215 465138314 ONCOL SUP ORG MA 501(c)(3) Type 1 DFCI true DANA-FARBERPARTNERS CANCER CARE 450 Brookline Avenue BP418 BOSTON MA 02215 043402364 ONCOLOGY PTNR MA related 40820307 false 0 0.50000 false true true false false false false false false false false true false false true false false true true Dana-Farber Partners Cancer Care Inc O 136551 CASH Dana-Farber Partners Cancer Care Inc R 219245 CASH Dana-Farber Partners Cancer Care Inc L 33709329 CASH Dana-Farber Inc R 31121955 CASH Dana-Farber Inc S 194125882 CASH Friends of Dana-Farber Cancer Institute Inc O 225500 Actual Expense RMSA Trust R 161018 CASH Friends of Dana-Farber Cancer Institute Inc B 50000 Cash Friends of Dana-Farber Cancer Institute Inc C 576203 Cash Dana-Farber Cancer Care Network Inc l 34160602 cost Dana-Farber Cancer Care Network Inc S 41247040 cost Dana-Farber Trust Inc c 273788 Cash Friends of Dana-Farber Cancer Institute Inc o 11500 Actual Expense